Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples